Evidence map›Paper›PMID 35205754›Full record

ReviewCancers2022

Current Status of the Spectrum and Therapeutics of

Sung-Hsin Kuo, Kun-Huei Yeh, Chung-Wu Lin, Jyh-Ming Liou, Ming-Shiang Wu, Li-Tzong Chen, Ann-Lii Cheng

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Role of non-World journal of gastroenterology · 2023
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Sung-Hsin KuoDepartment of Oncology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei 100, Taiwan.ORCID 0000-0003-0054-887X
Kun-Huei YehDepartment of Oncology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei 100, Taiwan.
Chung-Wu LinDepartment of Pathology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei 100, Taiwan.
Jyh-Ming LiouDepartment of Internal Medicine, National Taiwan University Cancer Center, National Taiwan University College of Medicine, Taipei 106, Taiwan.
Ming-Shiang WuDepartment of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei 100, Taiwan.
Li-Tzong ChenNational Institute of Cancer Research, National Health Research Institutes, Tainan 704, Taiwan.
Ann-Lii ChengDepartment of Oncology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei 100, Taiwan.ORCID 0000-0002-9152-6512
National Taiwan University · TWNational Taiwan University Hospital · TWKaohsiung Medical University · TW

Funding

National Taiwan University Hospital NUTH 111-S0063
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bacteriaHelicobacter pyloriimmunomodulatory drugslymphomagenesismacrolidesMALTnegativespectrum

Identifiers

PMID35205754
PMCPMC8869919
OpenAlexW4213031656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.